| ²é¿´: 669 | »Ø¸´: 2 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
wu_juan½ð³æ (ÕýʽдÊÖ)
|
[½»Á÷]
ÇóÖúICH: Q7AºÍQ9µÄÄÚÈÝ
|
||
|
ICH.Q7A:Good Practice Guide:Validation of Laboratory Computerized Systems.ISPE:Tampa,FL,2005 ICH.Q9:Quality Risk Management.Federal Register 71(106£©June 2006:32105-32106 ·¢×ÔСľ³æAndroid¿Í»§¶Ë |
» ²ÂÄãϲ»¶
2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË
ÒѾÓÐ22È˻ظ´
µ¼Ê¦Í²ۣºÎÒÔõô̯ÉÏÁËÕâô¸ö¼«Æ·Ñо¿Éú£¡
ÒѾÓÐ3È˻ظ´
2026ÄêµÄ¹ú¼ÒÉç¿Æ»ù½ðÏîĿͨѶÆÀÉóµÄйæÔòÓëж¯Ïò¡¢ÐÂÌôÕ½
ÒѾÓÐ7È˻ظ´
½ñÌì»ù½ð»á³ö½á¹ûÂð£¿20260819
ÒѾÓÐ18È˻ظ´
ÎÒÃæÉÏÍêµ°ÁË
ÒѾÓÐ14È˻ظ´
·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë
ÒѾÓÐ8È˻ظ´
Ö»ÓÐÿÄêÕâÖÖʱºòÀ´¹ä¹äСľ³æ
ÒѾÓÐ27È˻ظ´
Ã÷ÌìÓ¦¸Ã¿É²éÁË£¡£¿
ÒѾÓÐ5È˻ظ´
Èç¹û´Ë¿ÌÄãÕýÔÚΪ¹ú»ù¸Ðµ½½¹ÂÇ£¬²»·ÁÀ´ÌýÌýÕâÊס¶»ù½ðÖ®Íâ¡·
ÒѾÓÐ7È˻ظ´
ûÓÐÈκÎÏûÏ¢-ÊDz»ÊǾÍÁ¹ÁË
ÒѾÓÐ8È˻ظ´
wu_juan
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1241.5
- É¢½ð: 89
- ºì»¨: 6
- Ìû×Ó: 436
- ÔÚÏß: 58.6Сʱ
- ³æºÅ: 4168664
- ×¢²á: 2015-10-23
- ÐÔ±ð: MM
- רҵ: Ò©Îï·ÖÎö
3Â¥2016-04-27 14:37:05
zhqw423
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 13 (СѧÉú)
- ½ð±Ò: 3280.5
- É¢½ð: 521
- ºì»¨: 5
- ɳ·¢: 3
- Ìû×Ó: 1297
- ÔÚÏß: 138.7Сʱ
- ³æºÅ: 457748
- ×¢²á: 2007-11-12
- ÐÔ±ð: GG
- רҵ: ΢ÉúÎïѧ
¡ï ¡ï ¡ï ¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
wu_juan: ½ð±Ò+3, ллÈÊÐÖ£¬ºÃ¾ÃµÄÌû×ÓÁË 2016-04-27 14:37:42
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
wu_juan: ½ð±Ò+3, ллÈÊÐÖ£¬ºÃ¾ÃµÄÌû×ÓÁË 2016-04-27 14:37:42
| Ó¢ÎĺÍÖÐÎĵ쬲»¹ý²»ÖªµÀÓÐûÓиüС£ |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : ICH-Q7a£¨ÖÐÓ¢ÎĶÔÕÕ£©.pdf
- ¸½¼þ 2 : Q7a_Good_Manufacturing_Practice_Guide_for_Active_Pharmaceutical_Ingredients_.pdf
- ¸½¼þ 3 : Q9_Quality_Risk_Management.pdf
- ¸½¼þ 4 : Q9_ÖÊÁ¿·çÏÕ¹ÜÀí.pdf
2016-04-27 14:14:57, 574.96 K
2016-04-27 14:14:58, 256.8 K
2016-04-27 14:15:08, 112.63 K
2016-04-27 14:15:09, 76.42 K

2Â¥2016-04-27 14:15:37









»Ø¸´´ËÂ¥
20